Celebrating our Fifth Year of Operations 🎂

RTP, NC, December 9, 2022 — We are pleased to announce that GeneCoda® recently hit a milestone that we are extremely excited about. This could not have been accomplished without the terrific clients, team, and Advisory Board we’ve been fortunate to partner with over the years.

As we enter our fifth year of operations this holiday season, we’re grateful for the amazing clients we’ve served. These clients are at the inception of new frontiers in medicine and are dedicated to solving challenging problems that impact the health and lives of the patients they serve.

Among others, these clients’ technologies include.

• Machine learning in drug discovery
• Novel CAR targets focused in Oncology
• Monoclonal antibodies
• Drug discovery and development consulting services
• HT instrumentation focused on antibody screening
• Gene editing
• Advanced imaging
• Wound healing
• Alzheimer’s therapeutics
• Cell therapy

Most people are affected by disease and health conditions directly or indirectly during their lives. To contemplate that GeneCoda® might place a professional whose team discovers a cure or moderates a complex disease is more than enough reason for us to get to work! We are eager to continue placing top Life Sciences talent during this Golden Age of medicine where cures for genetic diseases like Cystic Fibrosis will exist.

Our philosophy is that service-sector firms are all about their people. It’s not about our firm and, in the end, we’re measured by the results of the people we place.

As we continue to expand our client roster and team, know that we are driven by the work you do on behalf of the patients you serve. We pause to express our gratitude to those who have helped us along this path. Thank you to our customers and friends of GeneCoda® for your continued engagement and we’re excited to see what advancements the next five years bring!